Biosimilars to Watch in 2024
With nine competitors launching in one year, Humira and its biosimilars held the pharmacy world’s focus in 2023. Biosimilars have...
With nine competitors launching in one year, Humira and its biosimilars held the pharmacy world’s focus in 2023. Biosimilars have...
Plan sponsors who need to find affordable ways to provide pharmacy benefits to members will often look to manufacturer copay...
Specialty drugs can treat or cure members with chronic, rare, and complex conditions, but they can also come with a...
In the 1990s, new technology made it possible for drug manufacturers to more easily replicate drugs. This meant that multiple...
When new drugs come to market for rare diseases – those that affect less than 200,000 Americans, often these...
Enjoy our latest blogs, white papers and news by signing up for our newsletter today!